Bay Colony Advisors’s Pfizer PFE Stock Holding History

Bay Colony Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$386K	Buy	16,031 +3,359	+27%	+$87.9K	0.04%	320
2026 Q1	$356K	Sell	12,672 -36	-0.3%	-$958	0.04%	346
2025 Q4	$316K	Sell	12,708 -6,039	-32%	-$152K	0.04%	377
2025 Q3	$478K	Sell	18,747 -47,046	-72%	-$1.16M	0.06%	305
2025 Q2	$1.59M	Buy	65,793 +9,236	+16%	+$215K	0.22%	91
2025 Q1	$1.43M	Buy	56,557 +1,400	+3%	+$36.6K	0.22%	97
2024 Q4	$1.46M	Sell	55,157 -2,168	-4%	-$58.8K	0.22%	97
2024 Q3	$1.66M	Sell	57,325 -4,530	-7%	-$132K	0.25%	88
2024 Q2	$1.73M	Sell	61,855 -4,529	-7%	-$125K	0.29%	76
2024 Q1	$1.84M	Buy	66,384 +25,960	+64%	+$720K	0.32%	71
2023 Q4	$1.16M	Sell	40,424 -37,358	-48%	-$1.13M	0.23%	96
2023 Q3	$2.58M	Buy	77,782 +8,518	+12%	+$301K	0.62%	34
2023 Q2	$2.54M	Buy	69,264 +1,459	+2%	+$56.8K	0.61%	37
2023 Q1	$2.74M	Sell	67,805 -2,354	-3%	-$102K	0.72%	28
2022 Q4	$3.59M	Sell	70,159 -3,129	-4%	-$150K	0.95%	21
2022 Q3	$3.21M	Sell	73,288 -3,691	-5%	-$179K	0.95%	18
2022 Q2	$3.89M	Sell	76,979 -3,652	-5%	-$186K	0.99%	18
2022 Q1	$4.17M	Buy	80,631 +18,690	+30%	+$970K	1%	15
2021 Q4	$3.66M	Buy	61,941 +6,192	+11%	+$307K	1.04%	9
2021 Q3	$2.4M	Buy	55,749 +9,711	+21%	+$430K	0.79%	24
2021 Q2	$1.8M	Buy	46,038 +3,256	+8%	+$127K	0.6%	41
2021 Q1	$1.55M	Buy	42,782 +5,811	+16%	+$206K	0.59%	43
2020 Q4	$1.36M	Sell	36,971 -3,775	-9%	-$138K	0.72%	35
2020 Q3	$1.42M	Buy	40,746 +12,533	+44%	+$439K	0.88%	22
2020 Q2	$875K	Buy	28,213 +7,085	+34%	+$241K	0.63%	50
2020 Q1	$654K	Buy	21,128 +7,424	+54%	+$253K	0.59%	59
2019 Q4	$523K	Sell	13,704 -11,757	-46%	-$419K	0.34%	103
2019 Q3	$868K	Buy	25,461 +12,941	+103%	+$471K	0.59%	50
2019 Q2	$515K	Buy	12,520 +351	+3%	+$13.9K	0.33%	87
2019 Q1	$488K	Buy	12,169 +851	+8%	+$34.1K	0.32%	90
2018 Q4	$469K	Buy	11,318 +1,174	+12%	+$48.7K	0.4%	70
2018 Q3	$424K	Buy	10,144 +1,562	+18%	+$60.1K	0.32%	93
2018 Q2	$295K	Buy	+8,582	New	+$293K	0.21%	106

Other funds holding PFE

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

ORIO

Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return

Bay Colony Advisors's PFE Position: Q2 2026 in Review

Bay Colony Advisors increased its Pfizer (PFE) stake by 27% in Q2 2026, buying an estimated $87.9K and bringing the position to 16,031 shares worth $386K. The position accounts for 0.04% of the portfolio, ranked #320.

Bay Colony Advisors first reported a position in PFE in Q2 2018 and has held it in 33 quarters since. The position peaked at $4.17M in Q1 2022. 752 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Bay Colony Advisors held 16,031 shares of Pfizer worth $386K as of Q2 2026.
Bay Colony Advisors bought 3,359 Pfizer shares in Q2 2026, an estimated $87.9K.
Pfizer made up 0.04% of Bay Colony Advisors's portfolio in Q2 2026, its #320 holding.
Bay Colony Advisors first reported a position in Pfizer in Q2 2018 and has held it in 33 quarters since.
Bay Colony Advisors's Pfizer position peaked at $4.17M in Q1 2022.
752 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Bay Colony Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.